Joint (JYNT) Expected to Release Quarterly Earnings on Thursday

Joint (NASDAQ:JYNT) is anticipated to release its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect Joint to post earnings of $0.0467 per share and revenue of $14.5730 million for the quarter. Interested persons may visit the the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, August 6, 2026 at 5:00 PM ET.

Joint (NASDAQ:JYNT) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.08 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.05. The business had revenue of $14.82 million during the quarter, compared to analyst estimates of $14.50 million. Joint had a net margin of 5.72% and a return on equity of 7.00%. On average, analysts expect Joint to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Joint Stock Performance

Shares of NASDAQ JYNT opened at $8.29 on Tuesday. The firm’s 50 day moving average price is $8.83 and its 200-day moving average price is $8.92. The company has a market cap of $118.20 million, a PE ratio of 35.87 and a beta of 1.10. Joint has a 52-week low of $7.50 and a 52-week high of $11.26.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on JYNT shares. Wall Street Zen lowered shares of Joint from a “strong-buy” rating to a “buy” rating in a report on Sunday, June 7th. Weiss Ratings raised Joint from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, June 12th. Finally, Zacks Research downgraded Joint from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 7th. Three equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Joint presently has an average rating of “Hold” and an average target price of $18.00.

Insiders Place Their Bets

In related news, major shareholder Charles E. Jobson bought 127,676 shares of the stock in a transaction on Tuesday, May 12th. The shares were acquired at an average price of $8.57 per share, for a total transaction of $1,094,183.32. Following the purchase, the insider owned 1,773,479 shares of the company’s stock, valued at approximately $15,198,715.03. The trade was a 7.76% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 30.20% of the company’s stock.

Institutional Trading of Joint

Large investors have recently made changes to their positions in the stock. JCP Investment Management LLC bought a new position in Joint during the second quarter valued at approximately $5,526,000. Topline Capital Management LLC grew its position in Joint by 18.7% in the 2nd quarter. Topline Capital Management LLC now owns 449,204 shares of the company’s stock worth $5,184,000 after purchasing an additional 70,910 shares during the period. Geode Capital Management LLC grew its position in Joint by 17.6% in the 2nd quarter. Geode Capital Management LLC now owns 345,330 shares of the company’s stock worth $3,986,000 after purchasing an additional 51,704 shares during the period. State Street Corp raised its stake in Joint by 0.8% during the 4th quarter. State Street Corp now owns 292,123 shares of the company’s stock valued at $2,547,000 after buying an additional 2,341 shares during the last quarter. Finally, First Foundation Advisors raised its stake in Joint by 47.8% during the 3rd quarter. First Foundation Advisors now owns 273,759 shares of the company’s stock valued at $2,612,000 after buying an additional 88,486 shares during the last quarter. 76.88% of the stock is currently owned by institutional investors.

Joint Company Profile

The Joint Chiropractic, Inc, doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint’s growth strategy centers on partnering with franchisees to expand its network of clinics.